Rap video is latest evidence in Insys trialA rap video used to motivate Insys Therapeutics’ salesforce into promoting higher doses of its opioid drug Subsys Share XRap video is latest evidence in Insys trialhttps://pharmaphorum.com/news/rap-video-is-latest-evidence-in-insys-trial/
Bayer/Orion showcase results from prostate cancer challengerBayer and development partner Orion have released detailed results from the trial that will form the backbone of Share XBayer/Orion showcase results from prostate cancer challengerhttps://pharmaphorum.com/news/bayer-orion-showcase-results-from-prostate-cancer-challenger/
Price cut unlocks NICE nod for Perjeta in post-surgery breast cancerRoche has finally won NICE backing for the use of Perjeta (pertuzumab) to prevent early-stage HER2-positive breast cancer Share XPrice cut unlocks NICE nod for Perjeta in post-surgery breast cancerhttps://pharmaphorum.com/news/price-cut-unlocks-nice-nod-for-perjeta-in-post-surgery-breast-cancer/
Tackling adherence is “only sustainable path to profit”Every year, pharmaceutical companies lose an eye-watering $637bn through medication non-adherence – so why isn’t the industry taking Share XTackling adherence is “only sustainable path to profit”https://pharmaphorum.com/views-analysis-sales-marketing/tackling-adherence-is-only-sustainable-path-to-profit/
Changing heartsDanish biotech Acesion Pharma is hoping to change the standard of care in atrial fibrillation. Richard Staines spoke Share XChanging heartshttps://pharmaphorum.com/views-and-analysis/changing-hearts/
The happiness factorAs part of pharmaphorum’s Eye on Innovation series, Richard Staines spoke to John Zibert, chief medical officer at Share XThe happiness factorhttps://pharmaphorum.com/r-d/views-analysis-r-d/happiness-factor-dermatological-conditions/
Deep Dive: Disruptive TechnologiesIn the first issue of Deep Dive for 2019, we look at disruptive technologies in pharma, how they’re Share XDeep Dive: Disruptive Technologieshttps://pharmaphorum.com/digital/disruptive-technologies-pharma-2019/
European digital health innovationHealthcare and the pharmaceutical industry are redefining their roles for the modern age as digital health tech radically Share XEuropean digital health innovationhttps://pharmaphorum.com/digital/european-digital-health-innovation/
CAR-Ts – a new weapon in the fight against cancerCAR-T – or Chimeric Antigen Receptor T-cell therapies herald a new wave of therapies in cancer. CAR-T therapies Share XCAR-Ts – a new weapon in the fight against cancerhttps://pharmaphorum.com/views-and-analysis/car-ts-a-new-weapon-in-the-fight-against-cancer/
Navigating new frontiers: Ways to find space in the future RA market Share XNavigating new frontiers: Ways to find space in the future RA markethttps://pharmaphorum.com/r-d/navigating-new-frontiers-ways-to-find-space-in-the-future-ra-market/
The 2nd Life Sciences Sector Deal and the NHS 10 Year Plan Share XThe 2nd Life Sciences Sector Deal and the NHS 10 Year Planhttps://pharmaphorum.com/market-access-2/the-2nd-life-sciences-sector-deal-and-the-nhs-10-year-plan/
Cancer, genomics and personalised medicine: Modelling oncology’s future Share XCancer, genomics and personalised medicine: Modelling oncology’s futurehttps://pharmaphorum.com/oncology/cancer-genomics-and-personalised-medicine-modelling-the-future-of-oncology/
Acting on the moments that matter to build a brandAll too often pharmaceutical marketing orthodoxy says to focus on just one area – a product’s launch, in Share XActing on the moments that matter to build a brandhttps://pharmaphorum.com/sales-marketing/acting-on-the-moments-that-matter-to-build-a-brand/
Designing behavioural science-based patient support programmesWe all exhibit behaviours that are, at times, irrational, and this presents a major challenge for pharmaceutical companies Share XDesigning behavioural science-based patient support programmeshttps://pharmaphorum.com/sales-marketing/designing-behavioural-science-based-patient-support-programmes/
Adherence – Don’t Remind Me!The benefits of adherent patients are no secret: better outcomes, a more stable treatment pathway and of course Share XAdherence – Don’t Remind Me!https://pharmaphorum.com/sales-marketing/adherence-dont-remind-me/
Biotech strategy and nanomedicine: the pharmaphorum podcast Share XBiotech strategy and nanomedicine: the pharmaphorum podcasthttps://pharmaphorum.com/r-d/biotech-strategy-and-nanomedicine/
The future of pharma in a digital world Share XThe future of pharma in a digital worldhttps://pharmaphorum.com/digital/healthlive-the-future-of-pharma-in-a-digital-world/
Raising the bar in liver cancer therapy Share XRaising the bar in liver cancer therapyhttps://pharmaphorum.com/oncology/insights-oncology/raising-bar-liver-cancer-therapy/
Explore the role of data science at Adaptive Designs in Clinical Trials Share XExplore the role of data science at Adaptive Designs in Clinical Trialshttps://pharmaphorum.com/partner-content/explore-the-role-of-data-science-at-adaptive-designs-in-clinical-trials/
Registration opens for SMi’s 4th Pre-filled Syringes West Coast 2019 Share XRegistration opens for SMi’s 4th Pre-filled Syringes West Coast 2019https://pharmaphorum.com/partner-content/registration-opens-for-smis-4th-pre-filled-syringes-west-coast-2019/
Combating Antifungal Resistance to be discussed at Superbugs & Superdrugs Conference Share XCombating Antifungal Resistance to be discussed at Superbugs & Superdrugs Conferencehttps://pharmaphorum.com/partner-content/combating-antifungal-resistance-to-be-discussed-at-superbugs-superdrugs-conference/
SMi’s 3rd Annual 3D Cell Culture Conference takes place in 2 weeks Share XSMi’s 3rd Annual 3D Cell Culture Conference takes place in 2 weekshttps://pharmaphorum.com/partner-content/smis-3rd-annual-3d-cell-culture-conference-takes-place-in-2-weeks/
pharmaphorum welcomes George Underwood to its editorial helm Share Xpharmaphorum welcomes George Underwood to its editorial helmhttps://pharmaphorum.com/news/pharmaphorum-welcomes-george-underwood-to-its-editorial-helm/
STEM Healthcare appoints Jason McKenna as CEO Share XSTEM Healthcare appoints Jason McKenna as CEOhttps://pharmaphorum.com/partner-content/stem-healthcare-appoints-jason-mckenna-as-ceo/
